Dr. Laurent Yvan-Charvet obtained his Ph.D. in Endocrinology in 2005 from the University of Paris XI, France. His research work at Columbia University has been mainly focused on how regulation of inflammation and stem cell biology by cholesterol efflux pathways affect cardiovascular diseases. He was the recipient of the Roger Davis Award in 2010, finalist of the I.H. Page Young Investigator Award in 2011, recipient of the EAS young Investigator Award in 2013 and the Daniel Steinberg Early Career Investigator Award in 2015. After a contribution to the development of new therapeutics for cardiovascular diseases at Pfizer, his current research interest as a Director of Research and group leader lies in hematopoietic cell metabolism – a new area of research for cardiovascular and inflammatory diseases. This work is supported by two most prominent French and European fundings: an Atip-Avenir excellence program and an European ERC consolidator excellence program.
|Sep. 12 (Sat)
Vascular Cell Biology 2
||Immunometabolic Fabric in Atherosclerosis